Measles in Healthcare Facilities in the United States during the Postelimination Era, 2001-2014

Clinical Infectious Diseases

Volumn 61, Issue 4, 2015, Pages 615-618

  Fiebelkorn, Amy Parker ^a   Redd, Susan B ^a   Kuhar, David T ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

economic; healthcare facilities; healthcare personnel; measles transmission; vaccine failure

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; COST OF ILLNESS; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; MEASLES; MEASLES VACCINATION; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; UNITED STATES; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; ECONOMICS; PROCEDURES; TRANSMISSION;

COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HEALTH CARE COSTS; HEALTH FACILITIES; HUMANS; MEASLES; OCCUPATIONAL EXPOSURE; UNITED STATES;

EID: 84938592564     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ387     Document Type: Article

References (17)

1. Strebel PM, Papania MJ, Parker Fiebelkorn A, Halsey N. Measles vaccine. In: Plotkin SA, OrensteinWA, Offit P, eds. Vaccines. 6th ed. Elsevier Saunders, 2013:352-87.
2. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189(suppl 1):S43-7.
3. Fiebelkorn AP, Seward JF, Orenstein WA. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine 2014; 32:4823-39.
4. Chen SY, Anderson S, Kutty PK, et al. Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis 2011; 203:1517-25.
5. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60(RR-7):1-45.
6. Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis 2011; 204(suppl 1):S559-63.
7. O'Donnell A, Lavin M, Bardowski L, Silkaitis C, Bolon M, Zembower T. Impact of a measles exposure in an emergency department. Am J Infect Control 2010; 38:E41-2.
8. Helmecke MR, Elmendorf SL, Kent DL, Pauze DK, Pauze DR. Measles investigation: a moving target. Am J Infect Control 2014; 42:911-5.
9. Parker AA, Staggs W, Dayan GH, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 2006; 355:447-55.
10. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. 2007; 35:S65-164.
11. Ammari LK, Bell LM, Hodinka RL. Secondary measles-vaccine failure in health-care workers exposed to infected patients. Infect Cont Hosp Epidemiol 1993; 14:81-6.
12. Lievano FA, Papania MJ, Helfand RF, et al. Lack of evidence of measles virus shedding in people with inapparent measles virus infections. J Infect Dis 2004; 189(suppl 1):S165-70.
13. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis 2014; 58:1205-10.
14. Yeung LF, Lurie P, Dayan G, et al. A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics 2005; 116:1287-91.
15. Paunio M, Peltola H, Valle M, Davidkin I, Virtanen M, Heinonen OP. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol 1998; 148:1103-10.
16. Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990; 263:2467-71.
17. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis 2007; 196:1459-64.